Targeted Antifibrotic (Nintedanib) & Endobronchial Valve Therapy

Click to Expand

COPD & pulmonary fibrosis management Fullscreen View

Clinical Summary

Clinical Overview & Disease Information

Dual bronchodilators, antifibrotic Nintedanib/Pirfenidone, and Zephyr endobronchial valves for lung volume reduction.

Clinical Insight: Undergoing copd & pulmonary fibrosis management at our accredited centers provides international patients with access to state-of-the-art navigation robotics, intraoperative neuromonitoring, and world-renowned surgical teams at a fraction of Western costs.

Clinical Manifestations

Signs & Symptoms

Early Symptoms

• • Early respiratory symptoms
• • Mild Progressive breathlessness, dry cough, low SpO2, honeycombing on HRCT

Common Symptoms

• • Persistent Progressive breathlessness, dry cough, low SpO2, honeycombing on HRCT
• • Shortness of breath on exertion
• • Chronic cough or wheezing

Emergency Symptoms

• • Acute respiratory failure SpO2 < 88%
• • Massive hemoptysis or severe pneumothorax

Etiology & Demographics

Causes & Risk Factors

Primary Causes & Etiology

• COPD & Idiopathic Pulmonary Fibrosis (IPF)
• Tobacco smoke & occupational dust exposure
• Airway hyperresponsiveness & parenchymal fibrosis

Who is at Higher Risk?

• Patients diagnosed with COPD & Idiopathic Pulmonary Fibrosis (IPF)
• Patients requiring expert pulmonology care

Pre-Operative Protocol

Diagnostic Evaluation & Testing

Diagnostic Test	Clinical Purpose / What It Shows
HRCT Chest & Spirometry PFT Assessment for COPD & pulmonary fibrosis management	High-resolution anatomical imaging and pulmonary function evaluation

Surgical Techniques

Comprehensive Treatment Options

Minimally Invasive: Interventional / VATS Surgery for COPD & pulmonary fibrosis management

Primary Choice

Board-certified pulmonologist or thoracic surgeon executed procedure.

Key Advantages:

Minimally invasive keyhole or endoscopic approach

Preserves lung capacity

High clinical success

Multidisciplinary Pulmonary Care for COPD & pulmonary fibrosis management

Complex Cases

Comprehensive surgical or medical therapy protocol.

Recommended For:

Advanced pulmonary pathology

Failed initial medical therapy

Advanced Medical Technologies Available in Partner Hospitals

Uniportal VATS Surgery EBUS-TBNA Staging Zephyr Endobronchial Valves

Clinical Risk Warning

Possible Complications If Untreated

Transient air leak

Bronchoscopic irritation

Post-procedure cough

Post-Operative Milestone

Recovery Timeline, Diet & Lifestyle Care

Recovery Timeline

Procedure / Stage	Expected Recovery Duration
Post-Procedure Recovery	24 to 48 hours
Chest Drain Removal / Discharge	3 to 5 days
Full Active Living	2 to 3 weeks

Recommended Post-Treatment Diet

• High protein balanced nutrition
• Hydration 2.5L/day

Essential Lifestyle Changes

• Perform incentive spirometry daily
• Strict complete smoking cessation

When to Contact a Doctor Urgently:

Sudden shortness of breath

Coughing up fresh blood

Fever > 100.4°F

Long-Term Health

Prevention & Long-Term Health

Complete smoking cessation and annual low-dose CT screening for smokers

Transparent Benchmark

Global Cost Comparison Matrix

Procedure	USA (Avg)	India (ISG Network)	Turkey (Avg)	Thailand (Avg)
COPD & pulmonary fibrosis management	$35,000	$2,200	$8,500	$9,500

Patient Knowledgebase

Frequently Asked Questions

What is the goal of treatment for COPD & pulmonary fibrosis management?

The main goal is restoring optimal pulmonary function and resolving breathlessness under board-certified pulmonologists.